To Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects
Clinical trial NCT06543459 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06543459
- Sponsor
- Wuhan Createrna Science and Technology Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-10
- Primary completion
- 2024-09-27
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.